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Abstract
Background: Dendritic cells (DCs) are considered as key mediators of the early events in human
immunodeficiency virus type 1 (HIV-1) infection at mucosal sites. Previous studies have shown that
surface-bound virions and/or internalized viruses found in endocytic vacuoles of DCs are efficiently
transferred to CD4+ T cells. Extracellular adenosine triphosphate (ATP) either secreted or
released from necrotic cells induces a distorted maturation of DCs, transiently increases their
endocytic capacity and affects their migratory capacity. Knowing that high extracellular ATP
concentrations are present in situations of tissue injury and inflammation, we investigated the effect
of ATP on HIV-1 transmission from DCs to CD4+ T lymphocytes.
Results: In this study, we show that extracellular ATP reduces HIV-1 transfer from immature
monocyte-derived DCs (iDCs) to autologous CD4+ T cells. This observed decrease in viral
replication was related to a lower proportion of infected CD4+ T cells following transfer, and was
seen with both X4- and R5-tropic isolates of HIV-1. Extracellular ATP had no effect on direct CD4+
T cell infection as well as on productive HIV-1 infection of iDCs. These observations indicate that
extracellular ATP affects HIV-1 infection of CD4+ T cells in trans with no effect on de novo virus
production by iDCs. Additional experiments suggest that extracellular ATP might modulate the
trafficking pathway of internalized virions within iDCs leading to an increased lysosomal
degradation, which could be partly responsible for the decreased HIV-1 transmission.
Conclusion: These results suggest that extracellular ATP can act as a factor controlling HIV-1
propagation.
Background
Dendritic cells (DCs) are crucial in generating a virus-spe-
cific immune response since they are recognized as the
most potent antigen-presenting cells of the immune sys-
tem, yet they also play a pivotal role in establishment and
dissemination of HIV-1 infection. Indeed, HIV-1 exploits
the migratory ability of DCs to gain access to CD4+ T lym-
phocytes in lymphoid tissues. DCs, particularly immature
DCs (iDCs) that reside in peripheral mucosal tissues, are
among the first target cells for the virus. The reported low
levels of CD4 and chemokine co-receptors CXCR4 and
CCR5 on DCs are probably responsible for their weaker
susceptibility to productive HIV-1 infection in vitro as
compared to CD4+ T cells [1,2]. It has been demonstrated
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C-type lectin receptors such as DC-specific intercellular
adhesion molecule 3-grabbing nonintegrin (DC-SIGN)
[3,4], mannose receptor (MR) (CD206) and galactosyl
ceramide [5] result in an efficient capture of viral particles.
Following interactions with the viral entity, DCs then
migrate to lymphoid tissues where their contact with
CD4+ T cells promotes a highly potent viral transfer,
resulting in vigorous HIV-1 replication. Although viruses
can remain either surface-bound or be taken up into
endolysosomal vacuoles, the origin of the transferred
virus is still a matter of debate and could be different in
iDCs versus mature DCs (mDCs) [6-10]. Interestingly,
HIV-1 transfer from DCs to CD4+ T cells was shown to
occur in two phases [11], which are not necessarily
sequential or interdependent [12]. In the initial transfer
phase (i.e. early transfer or trans-infection) the virus
located within DCs rapidly relocate at the DC/T-cell con-
tact zone, this locally virus-concentrated region between
the two cell types being referred to as the virological syn-
apse [9,13]. The second phase (i.e. late transfer or cis-
infection) is dependent on productive infection of DCs
and eventual transfer of progeny virus to CD4+ T cells [14].
A viral particle encountering an iDC can have different
fates. Entry using CD4/co-receptor complexes will lead to
viral replication and transfer of progeny virus. On the
other hand, after capture by a DC-SIGN-mediated endocy-
tosis process, the majority of virus particles will be
degraded inside endolysosomal compartments followed
by an antigenic presentation in the context of major histo-
compatibility complex class II molecules. A recent report
has demonstrated that an interaction between DC-SIGN
and leukocyte-specific protein A helps to shuttle HIV-1
particles to the proteasome, thereby promoting their
eventual degradation [15]. A small fraction of such endo-
cytosed virions will escape processing and retain their
infectivity. These viruses may be released to the cyto-
plasm, leading to DC infection [16], or remain protected
from degradation in a low pH compartment lacking early
or late endosomal markers and are later relocated to the
virological synapse [9,13,17]. The molecular mechanisms
governing HIV-1 storage and transfer by DCs are still
poorly understood. For example, the signals leading to the
formation of the virological synapse have yet to be identi-
fied. Also, little is known about the contribution of intra-
cellular signal transducers in virus capture and transfer,
although it has been recently demonstrated that Src and
Syk tyrosine kinases play a functional role in productive
HIV-1 infection of iDCs [18].
Extracellular nucleotides have emerged as important regu-
lators of the immune response [19]. Adenosine 5'-triphos-
phate (ATP) is present at high concentrations in the
cytosol and intracellular compartments, and can be
secreted by many cell types including epithelial and
endothelial cells, platelets, macrophages and activated T
lymphocytes [20]. In addition, ATP is released in large
amounts upon plasma membrane damage or necrotic cell
death. Hence, ATP functions as an indicator of tissue
destruction for the immune system. It has been demon-
strated that ATP modulates the function of immune cells
by activating two groups of purinergic receptors: P2X
receptors, which are ligand-gated cation channels, and the
seven membrane-spanning P2Y receptors, which are cou-
pled to G proteins [19]. An ATP exposure induces mostly
a proinflammatory response and it is now considered as a
danger signal to the immune system. Expression of both
receptor types has been reported in DCs [21], and extra-
cellular ATP exerts many effects on DC functions. In
monocyte-derived DCs, ATP was shown to induce a dis-
torted maturation state, with the up-regulation of costim-
ulatory and adhesion molecules (e.g. CD54, CD80, CD83
and CD86), an increased capacity to migrate to lymph
nodes associated with a modulation of the expression of
various chemokines and chemokine receptors, and a
reduced ability to attract Th1-type lymphocytes [22,23].
In addition, ATP inhibits LPS- and CD40L-induced pro-
duction of interleukin (IL)-1α and β, tumor necrosis fac-
tor (TNF)-α, IL-6 and IL-12 [22,24], but synergize with
TNF-α in the activation of DCs [25]. More recently, ATP
was shown to up-regulate two genes in DCs that are
involved in immunosuppression, i.e. thrombospondin-1
and indoleamine 2,3-dioxygenase [26]. At high concen-
trations, ATP induces profound morphological changes
and apoptotic cell death [27]. Interestingly, ATP affects
also the endocytic activity [22,25] and induces actin reor-
ganization [28] in human DCs.
Knowing that an increase in extracellular ATP concentra-
tions is seen in situations of tissue injury, inflammation or
microbial invasion, we investigated the effect of ATP on
HIV-1 transfer from DCs to CD4+ T lymphocytes. Here we
show that a short exposure to extracellular ATP causes a
decrease in viral transfer from iDCs to autologous CD4+ T
cells. Additional studies indicate that ATP modulates the
first phase of virus transfer, whereas the late transfer step
and de novo infection of iDCs are not affected. Our results
suggest that ATP exerts its effects partly by promoting deg-
radation of HIV-1 within iDCs. These results suggest that
extracellular ATP, which can be released under proinflam-
matory conditions, does not only act as a danger signal for
the immune system but also as a factor controlling HIV-1
transmission.
Results
Extracellular ATP diminishes HIV-1 transfer from DCs to 
CD4+ T cells
To study the possible consequences of ATP on HIV-1 cap-
ture by DCs and subsequent virus transfer to CD4+ T cells,
iDCs were first pulsed with R5-tropic NL4-3Balenv pro-Page 2 of 15
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were co-cultured with autologous CD4+ T cells without
any exogenous ATP. Data from studies using this experi-
mental design indicate that HIV-1 transfer is reduced by
the two concentrations of ATP tested (i.e. 100 and 500
μM) (Fig. 1A). Higher concentrations of ATP were found
to induce apoptosis in iDCs (i.e. >500 μM) (data not
shown) and were not used in the following experiments.
The fact that the observed inhibition is more significant at
earlier time points following initiation of the co-culture is
indicative of an ATP-dependent effect on interactions
between HIV-1 and iDCs. Indeed, virus infection is
spreading to the CD4+ T-cell population at later time
points and the ATP-directed modification of virus produc-
tion decreased with time. Similar observations were made
when using different virus preparations such as NL4-
3Balenv amplified in CD4+ T cells (Fig. 1B) or X4-tropic
viruses such as NL4-3 produced in 293T cells (Fig. 1C)
and the clinical isolate 92HT599 amplified in peripheral
blood mononuclear cells (PBMCs) (Fig. 1D). Altogether
data from these studies demonstrate that the ATP-induced
effect on HIV-1 transfer is not influenced by the viral iso-
late, tropism, or virus producer cell. The ATP-dependent
effect on virus propagation was found to be dose-depend-
ent when using iDCs as transmitter cells (Fig. 2a, left
panel). Although the maturation process of DCs results, as
Extracellular ATP reduces HIV-1 transfer from iDCs to autologous CD4+ T cellsFigur  1
Extracellular ATP reduces HIV-1 transfer from iDCs to autologous CD4+ T cells. iDCs were initially pulsed with 
R5-tropic NL4-3Balenv either produced upon transient transfection of 293T cells (A) or following acute infection of CD4+ T 
cells (B). In some experiments, iDCs were pulsed with X4-tropic viruses consisting of the laboratory variant NL4-3 produced 
upon transfection of 293T cells (C) or the clinical strain 92HT599 amplified in PBMCs (D). Pulsing was performed in absence 
or presence of the indicated concentrations of ATP for 60 min at 37°C. Next, iDCs were washed extensively to remove input 
virus and excess ATP and co-cultured with autologous CD4+ T cells at a 1:3 ratio. Virus production was assessed by measuring 
the cell-free p24 contents at the listed time points. Virus production at day 2 following initiation of the co-culture is depicted in 
the small inserts (upper left part of each panel). The data shown represent the means ± standard deviations of triplicate sam-
ples and are representative of four independent experiments for panels A, C and D, and three for panel B. Statistical analysis 
was performed on the results from all experiments. Asterisks denote statistically significant data (*, P < 0.05; **, P < 0.01).
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30expected, to a more significant virus transmission, the
ATP-mediated decrease in HIV-1 transfer is no longer seen
with mDCs (Fig. 2a&b, compare left and right panels).
Therefore, the next series of investigations were performed
with iDCs only.
HIV-1 is transferred to a smaller number of CD4+ T cells in 
the presence of ATP
To define if the observed ATP-driven decrease in virus pro-
duction in co-cultures made of iDCs and autologous
CD4+ T cells was caused by a reduced number of HIV-1-
infected CD4+ T cells, we used the NLHSA-IRES molecular
construct that we have recently engineered (Imbeault et
al., manuscript in preparation). This X4-tropic infectious
molecular clone of HIV-1 codes for all viral genes and also
for a cell surface reporter molecule, i.e. the murine heat-
stable antigen (HSA). Unlike most of the previous
reporter constructs, this plasmid will lead to the produc-
tion of fully infectious virions with no deletions in env, vpr
or nef, and allow the detection of productively infected
cells through the surface expression of the HSA molecule.
The pulsing of iDCs with such viruses followed by a co-
culture step with autologous CD4+ T cells for 3 days
resulted in a proportion of CD4+ T lymphocytes produc-
tively infected with HIV-1 ranging from 6.8 to 11.3% as
monitored by measuring the percentage of cells positive
for both HSA and CD3. This population of double posi-
tive cells was reduced by 25 to 46% when ATP was present
during the pulsing step. Flow cytometry data from a rep-
resentative experiment are depicted in Fig. 3. This observa-
tion suggests that treatment of iDCs with ATP leads to a
decrease in the number of CD4+ T cells productively
infected with HIV-1 following transfer of the virus by
iDCs.
ATP affects virus transfer from iDCs but not mDCsFigure 2
ATP affects virus transfer from iDCs but not mDCs. iDCs and mDCs from the same donor were first pulsed for 60 min 
at 37°C with R5-tropic JR-CSF either in absence or presence of ATP at the listed concentrations. Next, cells were washed 
extensively to remove input virus and co-cultured with autologous CD4+ T lymphocytes at a 1:3 ratio. Viral production was 
assessed at day 2 following initiation of the co-culture. Results from one representative experiment with triplicate samples are 
presented in panel A. The data shown in panel B represent the means ± standard deviations calculated from two independent 
experiments and are expressed as relative viral production compared to untreated cells. Asterisks denote statistically signifi-
cant data (**, P < 0.01).
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30ATP affects the early phase of transfer
Previous reports have shown that HIV-1 is efficiently
transferred from iDCs to CD4+ T cells via a process involv-
ing two distinct phases [7,11,18,29]. An initial transfer
phase occurs whereby intact viruses captured by iDCs are
transported to the DC-T cell synapse and transferred to
CD4+ T cells (i.e. early transfer or trans-infection). In a sec-
ond, slower process, a productive infection of iDCs results
in a potent transfer of newly formed viruses to CD4+ T
cells (i.e. late transfer or cis-infection). Knowing that the
late transfer phase occurs almost exclusively with R5-
tropic viruses and having shown that ATP affects equally
the transfer of both R5 and X4 viruses, we made the
hypothesis that the presence of ATP during DC pulsing
affect only the early transfer phase. To confirm this
hypothesis, iDCs were pretreated or not with the antiret-
roviral drug efavirenz before being used for HIV-1 transfer
studies. This treatment, by preventing productive infec-
tion of iDCs, allows only the first transfer phase to take
place. As expected, this treatment reduced the amount of
transferred viruses (Fig. 4A). However a comparable ATP-
mediated decrease in HIV-1 transmission was seen in both
untreated and efavirenz-treated cells (i.e. 53 versus 50%
inhibition, respectively). In addition, a similar decrease in
virus transfer was seen when using a single-cycle reporter
virus pseudotyped with a R5 envelope (Fig. 4B), therefore
substantiating the idea that ATP is acting on the trans-
infection process where the captured viruses are directed
to the DC-T-cell synapse. To confirm that ATP modulates
only this early transfer step, we analysed its effect on pro-
ductive infection in iDCs. To this end, iDCs were pulsed
with fully competent R5-using viruses (i.e. NL4-3Balenv)
in absence or presence of ATP and de novo virus produc-
tion was evaluated over time. Results illustrated in Fig. 4C
indicate that ATP has no effect on productive HIV-1 infec-
tion of iDCs and thus corroborate that ATP is not affecting
the second long-term transfer phase. Collectively, these
data suggest that only the first phase of viral transfer is
affected by ATP (i.e. trans-infection).
ATP affects virus degradation within iDCs
We next set out to shed light on the mechanism underly-
ing the ATP-mediated diminution in virus transfer. First
the impact of ATP treatment on the stimulatory capacity
of iDCs was evaluated in a mixed lymphocyte prolifera-
tion assay based on a previous report showing that ATP
HIV-1 is transferred to a lower number of CD4+ T cells in presence of ATPFigure 3
HIV-1 is transferred to a lower number of CD4+ T cells in presence of ATP. iDCs were either left untreated (mock) 
or pulsed for 60 min at 37°C with NLHSA-IRES (20 ng of p24/105 cells) in absence or presence of ATP (400 μM). Next, cells 
were extensively washed to remove input virus and co-cultured for 3 days with autologous CD4+ T cells. Cells were then 
stained for CD3 (FITC labeling) and HSA (R-PE labeling) and analyzed by flow cytometry. The percentage of HSA-expressing 
cells in the CD3-positive population is shown for three independent experiments.
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30modulates the T-cell stimulatory capacity of DCs follow-
ing a 48 h treatment [25]. Under our experimental condi-
tions (i.e. treatment with ATP for 60 min), ATP had no
effect on the stimulatory capacity of iDCs in a classical
mixed lymphocyte reaction assay in which control or ATP-
treated iDCs were cocultured with heterologous CD4+
lymphocytes (Fig. 5A). It has also been demonstrated that
ATP can induce a marked increase in expression of two
genes encoding for negative regulators of T lymphocyte
proliferation, namely thrombospondin-1 and indoleam-
ine 2,3-dioxygenase [26]. To investigate the possibility
that the release of such inhibitory mediators could affect
HIV-1 expression in CD4+ T cells, iDCs were incubated
with ATP for 60 min, washed to remove ATP and co-cul-
tured with autologous CD4+ T cells previously pulsed with
HIV-1-based reporter viruses pseudotyped with VSV-G.
Data from this series of investigations reveal that virus
gene expression in CD4+ T cells is similar upon coculture
with untreated or ATP-treated iDCs (Fig. 5B). Moreover,
virus production in acutely infected CD4+ T cells was not
affected by a prior exposure to extracellular ATP (Fig. 5C).
These results indicate that the ATP-mediated reduction in
HIV-1 transmission is not related to any direct effect of
extracellular ATP or ATP-treated iDCs on the process of
virus infection in CD4+ T cells. Thus ATP must act directly
on iDCs and modulates the HIV-1 life cycle by affecting
the level of viral entry, intracellular trafficking of virions
within the endosomal apparatus and/or formation of the
virological synapse.
It has been shown that HIV-1 can enter DCs either
through an endocytic pathway or fusion at the plasma
membrane following interaction with CD4 and CCR5.
This latter mode of virus entry leads to the cytosolic deliv-
Extracellular ATP affects the early transfer phaseFigur  4
Extracellular ATP affects the early transfer phase. (A) iDCs were initially either left untreated or treated with 50 nM 
efavirenz. Next, cells were either left untreated or treated with ATP before addition of NL4-3Balenv. Finally, cells were washed 
and co-cultured with autologous CD4+ T cells for 2 days before assessing viral production. The percentage of inhibition is 
shown above the appropriate bars. (B) Transfer studies were carried out using recombinant luciferase-encoding viruses pseu-
dotyped with the JR-FL envelope. Luciferase activity was assessed at 3 days following initiation of the co-culture. (C) iDCs were 
pulsed for 60 min with NL4-3Balenv in absence or presence of ATP (400 μM). Next, iDCs were extensively washed to remove 
input virus and cultured in complete culture RPMI medium supplemented with GM-CSF and IL-4. Cell-free supernatants were 
collected and assayed for the p24 content at the indicated days post-infection. Data shown represent the means ± standard 
deviations of triplicate samples and are representative of three (panels A and C) or two (panel B) independent experiments.
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30ery of viral material and results in productive infection, a
process that is not affected by ATP. On the other hand,
endocytosed viral particles can have two different fates,
i.e. degradation within the endosomal apparatus or stor-
age inside yet to be defined endocytic vacuoles followed
by a subsequent transfer at the virological synapse. To
analyze the effect of ATP on HIV-1 internalization, iDCs
were pulsed with HIV-1 particles in absence or presence of
ATP and, after removal of non-internalized particles by a
trypsin treatment and several washes, the amount of cell-
associated p24 was monitored. Results illustrated in Fig.
6A indicate that ATP causes a slight decrease in virus entry
in iDCs (i.e. 16% in the experiment shown in Fig. 6A).
Since the effect was variable and not consistently observed
among the different DC preparations tested (i.e. ranging
from 0 to 20%) (data not shown), we postulated that the
ATP-mediated effect on HIV-1 transfer could be related to
a very rapid degradation of internalized viruses during the
trypsin treatment and washes. We then analyzed virus
degradation and release over time. As shown in Fig. 6B,
the difference in intracellular p24 contents between
untreated and ATP-treated cells increases from 18% to
28% at the 1 and 3 h time points, thus suggesting a
slightly higher rate of virus degradation in ATP-treated
iDCs. It should be noted that the observed decrease in
intracellular p24 is caused by degradation rather than by
the release of viral particles since a very small amount of
p24 was recovered in the medium, and this amount was
similar in control and treated samples. To provide addi-
tional credence to the ATP-dependent effect on virus deg-
ATP is neither affecting the T-cell stimulatory capacity of iDCs nor virus production in CD4+ T cellsFigure 5
ATP is neither affecting the T-cell stimulatory capacity of iDCs nor virus production in CD4+ T cells. (A) iDCs 
were either left untreated or treated for 60 min at 37°C with the indicated concentrations of ATP. Next, cells were exten-
sively washed and co-cultured for 3 days with heterologous CD4+ T cells at a 1:10 ratio. Cellular proliferation was finally 
assessed using a colorimetric MTS assay. (B) iDCs were either left untreated or treated for 60 min at 37°C with the indicated 
concentrations of ATP. Next, iDCs were extensively washed and co-cultured with autologous CD4+ T cells that were previ-
ously pulsed with VSV-G-pseudotyped luciferase reporter viruses. Luciferase activity was assessed at 48 h following initiation of 
the co-culture. (C) CD4+ T cells were infected with NL4-3Balenv either in absence or presence of ATP (400 μM). Cells treated 
with the antiviral compound efavirenz (EFV) were used as controls. Virus production was monitored by measuring the cell-free 
p24 contents over time. Data shown represent the means ± standard deviations of triplicate samples and are representative of 
three independent experiments.
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30radation, iDCs were first pretreated with NH4Cl, a
lysomotropic weak base known to block endosomal acid-
ification [30] and lysosomal degradation [31], and next
used to transfer HIV-1 to autologous CD4+ T cells. As dem-
onstrated in Fig. 6C, the ATP-mediated diminution in
HIV-1 transmission is drastically reduced upon treatment
with NH4Cl (i.e. an average diminution of 50% in
absence of NH4Cl compared to a decrease of 18% in the
presence of NH4Cl for cells treated also with 400 μM of
ATP). This observation suggests that ATP acts at least
partly by inducing a more pronounced degradation of
HIV-1 in acidified endosomes.
ATP affects expression of some specific surface markers
A chronic exposure of iDCs to ATP has been shown to
induce a semi-maturation state characterized by an
increased expression of activation markers such as CD54,
CD80, CD83 and CD86 [22,25]. Previous findings indi-
cate that HIV-1 can use several different attachment fac-
tors to interact with DCs such as the C-type lectin
molecules DC-SIGN and MR. To analyze the conse-
quences of a brief ATP exposure on expression of these cell
surface markers, iDCs were either left untreated or treated
with ATP and/or NL4-3Balenv for 60 min and were then
thoroughly washed to remove ATP and/or viral particles.
Membrane expression of CD83, DC-SIGN and MR was
evaluated by flow cytometry either immediately following
ATP affects virus survival within iDCFigure 6
ATP affects virus survival within iDC. iDCs were initially pulsed for 60 min at 37°C with NL4-3Balenv in absence or pres-
ence of ATP (400 μM). Next, cells were washed extensively, treated with trypsin to remove uninternalized viruses and then 
either lysed immediately (A) or incubated at 37°C for the indicated time periods (B). The viral contents found either intracellu-
larly and in cell-free supernatant were assessed using a p24 test. The data shown represent the means ± standard deviations of 
triplicate samples and are representative of three independent experiments. In panel B, the upper part of each bar represents 
p24 recovered in the supernatant, whereas the intracellular p24 content is shown in the lower part of each bar. (C) iDCs were 
either left untreated or pretreated with NH4Cl (20 mM) for 30 min. Next, iDCs were pulsed for 60 min at 37°C with NL4-
3Balenv in absence or presence of the indicated concentrations of ATP. Cells were washed extensively to remove input virus 
and excess ATP and co-cultured with autologous CD4+ T cells at a 1:3 ratio. Viral production was assessed two days following 
initiation of the co-culture. The data shown represent the means ± standard deviations calculated from four independent 
experiments with triplicate samples and are presented as relative viral production of ATP-treated cells compared to control 
cells for each condition. The asterisk denotes statistically significant data (*, P < 0.05).
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30the 60 min treatment or 48 h later. Exposure to HIV-1 did
not significantly affect the surface expression levels of any
of the tested molecules at the two different time points
tested. In contrast, a minor but reproducible increase in
expression of the activation marker CD83 was induced
very rapidly by ATP followed by a significant induction at
the latest time point tested (Fig. 7). Interestingly, ATP was
found to diminish expression of the two HIV-1 attach-
ment factors DC-SIGN and MR but at the latest time point
tested (i.e. 48 h). Other markers of DC maturation such as
CD86 were also increased after ATP exposure (data not
shown). These data indicate that exposure to extracellular
ATP is sufficient to mediate profound changes in expres-
sion of cell surface constituents involved in the complex
interplay between HIV-1 and iDCs.
Discussion
Extracellular ATP that is released under inflammatory con-
ditions is now recognized as a potent stimulus for the ini-
tiation of immune responses through activation of DCs.
However, it may also play a role in preventing an exagger-
ated immune response by favouring an alternative DC
maturation that skew the immune reaction towards either
a Th2-type response or tolerance. Here we show that extra-
cellular ATP may fulfill an additional unexpected role in
the defence against infection by reducing HIV-1 transmis-
sion from iDCs to CD4+ T cells.
Several lines of evidence indicate that ATP is affecting pri-
marily HIV-1 trans-infection of CD4+ T-cells (i.e. early
transfer). First, the ATP-dependent reduction in virus
transfer is not modified when viral replication in iDC is
inhibited by an antiretroviral compound such as efa-
virenz. Second, ATP treatment has no effect whatsoever on
HIV-1 replication in iDCs in the absence of CD4+ T cells.
Third, the transfer of both X4- and R5-tropic viruses is
affected by ATP and it is known that replication of X4-
using virions in DCs is very inefficient [7,32]. Indeed pre-
vious studies have reported that X4 viruses do replicate
poorly and slowly in DCs and that only replicative viruses
are efficiently transferred few days after pulsing [14,16].
This could provide an explanation for the ATP-mediated
diminution in virus transfer that can be seen only in the
first 2–3 days following initiation of the co-culture. At
later time points, the detected viruses are newly formed
virions arising from replication within iDCs, which is not
affected by ATP.
Treatment of DCs with ATP has been shown previously to
induce up-regulation of two genes involved in immuno-
suppression, i.e thrombospondin-1 and indoleamine 2,3
dioxygenase [26]. It would then be plausible that such
mediators could impair HIV-1 infection of CD4+ T cells in
DC-T cell cocultures through an anti-proliferative effect,
leading to a decreased viral production. However, such a
mechanism is very unlikely since we demonstrate that
virus replication in autologous CD4+ T cells is not affected
upon co-culture with ATP-treated iDCs (Fig. 5). Moreover,
ATP treatment resulted in a similar effect on HIV-1 trans-
fer from iDCs to TZM-bl, a HeLa-derived indicator cell
line that is not sensitive to such inhibitors of cell prolifer-
ation (data not shown). Therefore, it can be proposed that
ATP influences HIV-1 transfer through a possible effect on
the complex interactions between iDCs and HIV-1 such as
binding and internalization, survival within endosomal
compartments and/or creation of the virological synapse.
Additional experiments demonstrate that ATP induces a
slight decrease in the process of HIV-1 internalization
(Fig. 6), but this effect is too weak and inconsistent to
explain the more dramatic reduction in virus transfer.
Hence, ATP must affect HIV-1 survival inside iDCs and/or
the signal that triggers movement of the virus-containing
organelles towards the infectious synapse. Treatment with
a weak base such as NH4Cl that inhibits endosomal acid-
ification greatly reduced the effects of ATP, therefore sug-
gesting that the ATP-mediated signal transduction
pathway either target viruses in different, more acidic
endosomal compartments or directly induce acidification
of HIV-1-containing intracellular organelles. Indeed,
endosomal acidification by a proton translocating ATPase
has been shown to be regulated via a Gi-mediated translo-
cation pathway [33], which is activated by P2Y receptors
upon ATP stimulation. Treatment with NH4Cl or chloro-
quine, another lysosomotropic agent, seems to have a
more dramatic effect in Raji-DC-SIGN cells where it com-
pletely abolishes transfer at low viral titers [8]. This con-
firms that transfer mechanisms are quite different in that
more artificial model system. In Raji-DC-SIGN cells,
viruses are transferred exclusively through DC-SIGN bind-
ing and only DC-bound viruses are transferred, whereas
several studies suggest that in human primary iDCs inter-
nalized viruses are transferred [7-11] and not exclusively
through DC-SIGN binding [5,16]. These discrepancies
indicate that observations made in cell lines should be
interpreted with caution, as they do not necessarily apply
to human primary cells. Besides, several observations sug-
gest that ATP could influence the intracellular trafficking
in DCs. For example, stimulation with ATP or other ago-
nists of the P2X7 receptor induces the release of microves-
icles containing various proteins such as caspases,
cathepsin D and the procoagulant tissue factor [34,35].
Moreover, ATP has been reported to modify the DC endo-
cytic activity [25] as well as to induce actin polymerization
and chemotaxis in DCs [28]. Surprisingly, a recent report
suggests that HIV-1 transmission is primarily due to the
transfer of DC surface-bound virions to CD4+ T cells [6].
However, other studies are more in accordance with the
importance of intracellular trafficking in the transfer. For
example monensin, an antibiotic that disrupts the Golgi
apparatus and inhibits vesicular transport, was shown toPage 9 of 15
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Retrovirology 2008, 5:30 http://www.retrovirology.com/content/5/1/30decrease DC-mediated HIV-1 transmission [10]. Although
our data with NH4Cl strongly suggest that, at least under
our experimental conditions, ATP affects the transfer of
internalized virions, we cannot completely rule out the
possibility that ATP could also impair transmission of sur-
face-bound virions, possibly by interfering with the clus-
tering of lipid rafts.
Our observation that extracellular ATP affects HIV-1 trans-
fer in iDCs, but not in mDCs, deserves a closer attention.
Since HIV-1 cannot productively infect mDCs [36], this
suggests that only viruses that are stored within intracellu-
lar organelles are transferred, similarly to the first phase in
iDCs which is affected by ATP. Interestingly, ATP appears
to induce profound modifications in iDCs but seems to
have little effect on mDCs. For example, although levels of
mRNAs coding for P2X and P2Y receptors do not change
during DC maturation, P2YR agonists were found to act as
chemotactic stimuli only in iDCs [28]. It is very unlikely
that the observed ATP-driven reduction in virus transfer
would be due to the previously reported semi-maturation
state induced by ATP [22,23] since mDCs have been
shown to efficiently transfer HIV-1. There might be pro-
found differences in the signalling induced by ATP in
iDCs versus mDCs. Additionally, the mechanisms respon-
sible for HIV-1 storage and transfer are quite different
between iDCs and mDCs. Indeed, it has been shown that
mDCs will propagate HIV-1 much more efficiently than
iDC, and independently of C-type lectins [10,37]. In addi-
tion, HIV-1 tends to accumulate in late endosomal com-
partments, close to the cell membrane in iDCs, whereas
viral particles are found in large complex vesicles in
mDCs, where they colocalize with tetraspanins CD9,
CD63 and CD81 [37-39]. Typically DC-SIGN acts as an
antigen receptor in iDCs and DC-SIGN/ligand complexes
are directed toward lysosomal compartments [40]. The
virus itself seems to be diverted from this pathway and
HIV-1/DC-SIGN complexes are directed to non-lysosomal
acidic organelles [8]. The exact mechanism(s) that gov-
erns this escape from lysosomal degradation is still
unclear but it is very likely that the ATP-mediated bio-
chemical events will modify this process by favouring
virus degradation. The fact that transfer from mDCs,
which does not depend on DC-SIGN, is not affected by
Surface expression of CD83, DC-SIGN and MR is affected by ATPFigur 7
Surface expression of CD83, DC-SIGN and MR is affected by ATP. iDCs (5 × 105) were either left untreated or 
treated for 60 min at 37°C with ATP (400 μM), NL4-3Balenv or ATP and NL4-3Balenv. Next, cells were extensively washed 
and either stained immediately or cultured for 48 h in complete medium before staining. Cells were stained with antibodies 
specific for CD83, DC-SIGN, or MR and analyzed by flow cytometry. Results from one representative experiment and flow 
data acquired after 48 h are presented. a %, Percentage of cells expressing the studied cell surface marker as defined by flow 
cytometry. Statistical analyses were performed on the results of three independent experiments (b, P < 0.01 ; c, P < 0.05).
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HIV-1 to the proteasome in DCs is mediated by the inter-
action between DC-SIGN and the leukocyte-specific pro-
tein 1 (LSP-1). In fact, it has been shown that down
regulation of LSP-1 will enhance HIV-1 transfer due to a
decreased virus degradation in the proteasome [15]. This
actin-binding cytosqueletal protein is regulated through
phosphorylation by various kinases including protein
kinase C and mitogen-activated protein kinase-activated
protein kinase 2 [41,42]. It is possible that the ATP-medi-
ated signal transduction events might interfere with this
regulation and enhance LSP-1 activity, leading to an
increased HIV-1 degradation in the proteasome with an
ensuing decrease in virus transfer.
Another indication that ATP might be affecting the endo-
somal recycling process is the small but consistent
increase in CD83 expression that can be seen immediately
following exposure of iDCs to ATP. Although not
expressed at the surface of iDCs, CD83 is preformed and
can be detected in perinuclear regions [43]. A previous
study has demonstrated that surface expression of CD83
in iDCs can be induced by inhibition of endocytosis [44].
It can thus be proposed that the ATP-mediated signals can
modify the recycling process leading to an increase in
CD83 surface expression but also to a decrease in viral
transfer. Conversely, extracellular ATP induces a decrease
in DC-SIGN expression. This decrease is too slow to have
any effect on HIV-1 internalization and in fact the impor-
tance of DC-SIGN for virus entry has been recently ques-
tioned [13]. Indeed, the inconsistent and minor reduction
in HIV-1 internalization in the presence of ATP is too
modest to account for the decrease in transfer efficiency.
The importance of DC-SIGN at later time points has been
controversial. Although some reports indicate an absence
of the DC-SIGN molecule at the DC-CD4+ T cell interface
[9], other studies indicate that DC-SIGN is required for
the formation of the infectious synapse (but not the for-
mation of DC-T cell conjugates) and indeed DC-SIGN
knock-down inhibits virus transmission by iDCs [13].
Hence, a diminished DC-SIGN expression following ATP
exposure could lead to a reduced number of DC-T cell
synapses, leading to a lower number of infected CD4+ T
cell (Fig. 3). A recent study has shown that DC-SIGN is
important only for the transfer of non-internalized virus,
whereas the galactosyl ceramide receptor would be crucial
for the transfer of internalized viruses [5]. It would be of
great interest to analyze the effect of extracellular ATP on
the expression and function of this receptor. Although
ATP is also inducing a reduced expression of MR at 48 h
following treatment, the precise contribution of MR in the
observed reduction in HIV-1 transfer is still undefined
given the paucity of data with respect to the involvement
of this C-type lectin receptor in some basic functions of
DCs such as endocytosis and antigen processing and pres-
entation.
Another possible event that could be affected by ATP is the
formation of the virological synapse. Before the contact
between DCs and CD4+ T cells, virus particles are evenly
distributed within DCs. However, upon a contact with
CD4+ T lymphocytes, viruses very rapidly become concen-
trated at the DC-T cell interface [9]. This observation sug-
gests that a signal is sent within DCs upon a contact with
CD4+ T cells, which triggers the formation of an infectious
synapse and directs HIV-1 trafficking towards that syn-
apse. It is then possible that ATP will affect that triggering
signal, then inhibiting the formation of a functional syn-
apse. Further analyses are required to identify the nature
of that signal, how it triggers the movement of virus-con-
taining organelles towards the infectious synapse, and
how exposure to extracellular ATP can possibly interfere
with this mechanism.
Conclusion
The ATP-mediated effect on viral transfer reveals obvious
implications for HIV-1 pathogenesis because DCs are not
only the first target cells following mucosal invasion with
HIV-1 but they are also the first line of defence against
such invasion. The primary role of these potent antigen
presenting cells as peripheral sentinels is to induce an effi-
cient immune response against pathogens. Extracellular
ATP, by interfering with HIV-1 transfer to CD4+ T cells and
promoting virus degradation within iDCs, might favour
the processing and presentation of viral antigenic peptides
that will lead to a specific antiviral response. The other
well-known effects of ATP on DC biology, i.e. cell activa-
tion and migration towards lymph nodes, might accentu-
ate further the HIV-1 specific immune response. Because
ATP is released from activated T lymphocytes, activated
platelets, or necrotic cells, its presence is a hallmark of
inflamed tissues. Indeed, with an intracellular concentra-
tion of ATP ranging from 5 to 10 mM, any plasma mem-
brane damage will promote a massive release of ATP.
Hence, although extracellular ATP concentrations have
been estimated to be in the low micromolar range due to
a rapid hydrolysis by ectonucleases [45], it is believed that
in inflamed tissues, the massive ATP release coupled with
a down-regulation of the ecto-ATPase CD39 may lead to
an accumulation of ATP which can reach very high con-
centrations in protected compartments [46]. Moreover, in
vivo studies have provided clear evidence for sustained
ATP release at sites of tissue injury [47,48]. The concentra-
tions used in our studies can then be easily attained in sit-
uations of tissue damage and inflammation. Our results
showing a reduced HIV-1 transfer from iDCs to autolo-
gous CD4+ T cells represent a new functional role for ATP
that is already considered as a constitutive danger signal
for the immune system.Page 11 of 15
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Reagents
ATP, phytohemagglutinin-L (PHA-L) and lipopolysaccha-
ride (LPS) were purchased from Sigma (St-Louis, MO).
Interleukin-2 (IL-2) and efavirenz were obtained through
the AIDS Repository Reagent Program (Germantown,
MD). Interferon-gamma (IFN-γ) and IL-4 were purchased
from R&D Systems (Minneapolis, MN), whereas GM-CSF
was a generous gift from Cangene (Winnipeg, MAN). The
culture medium consisted of RPMI 1640 supplemented
with 10% fetal bovine serum, penicillin G (100 U/ml),
streptomycin (100 U/ml) and glutamine (2 mM), which
were all purchased from Wisent (St-Bruno, QC).
Antibodies
The anti-CD3 OKT3 hybridoma (specific for the ζ chain of
the CD3 complex) was obtained from the American Type
Culture Collection (Manassas, VA). The anti-CD19 (clone
LT19) and anti-CD14 (clone MEM-18) were obtained
from EXBIO Praha (Prague, Czech Republic) while the
anti-CD83 (clone HP15E) was purchased from Research
Diagnostics (Concord, MA). The FITC-conjugated anti-
DC-SIGN (clone eB-h209) and anti-CD14 (clone 61D3)
were purchased from eBioscience (San Diego, CA). Phyco-
erythin (PE)-conjugated and FITC-conjugated goat anti-
mouse immunoglobulin G (IgG) were obtained from
Jackson ImmunoResearch Laboratories (West Grove, PA).
Cells
PBMCs were prepared by centrifugation on a Ficoll-
Hypaque density gradient as described previously [49,50].
Next, CD14+ cells (i.e. monocytes) were isolated by using
a positive selection kit according to the manufacturer's
instructions (MACS CD14 micro beads from StemCell
Technologies, Vancouver, BC). The CD14+ cells were cul-
tured in six-well plates at a density of 106 cells/ml. To gen-
erate iDCs, purified monocytes were cultured in complete
culture medium that was supplemented every other day
with GM-CSF (1,000 U/ml) and IL-4 (200 U/ml) for 7
days, and the maturation of DCs was induced on the fifth
day by culturing them for 48 h with the above-described
cytokines supplemented with IFN-γ (1,000 U/ml) and LPS
(100 ng/ml) as described previously [18,29]. Expression
of CD3 and CD19 was measured to assess contamination
with T and B cells, respectively. Autologous CD4+ T cells
were isolated using a negative selection kit according to
the manufacturer's instructions (StemCell Technologies),
activated with PHA-L (1 μg/ml) and maintained in com-
plete culture medium supplemented with IL-2 (30 U/ml)
at a density of 2 × 106 cells/ml. Experiments were per-
formed with cell preparations that were highly enriched in
the studied cell subpopulations (e.g. DCs: purity >95%;
CD4+ T cells: purity >98%).
Production of virus stocks
Virions were produced by transient transfection in human
embryonic kidney 293T cells as previously described [51].
Plasmids used include pNL4-3 (X4-tropic), pNLHSA-IRES
(X4-tropic), pJR-CSF (R5-tropic), pNL4-3Balenv (R5-
tropic), pNL4-3Luc+E-R+, pcDNA-1/Amp-based JR-FL
envelope (R5-tropic) and pHCMV-G. The pNL4-3Balenv
vector (provided by R. Pomerantz, Thomas Jefferson Uni-
versity, Philadelphia, PA) was generated by replacing the
env gene of the T-tropic HIV-1 strain, NL4-3, with that of
the macrophage-tropic HIV-1 Bal strain, thus resulting in
an infectious molecular clone with macrophage-tropic
properties [52]. The pNLHSA-IRES molecular construct
was obtained by replacing the eGFP gene in the NLENG1-
IRES vector (NL4-3 backbone) [53] with the coding
sequence for mouse heat stable antigen (HSA) (Imbeault
et al., manuscript in preparation). The luciferase-encoding
pNL4-3Luc+E-R+ and the R5-tropic envelope-encoding
pcDNA-1/Amp-based JR-FL envelope vectors were kindly
provided by N. R. Landau (The Salk Institute for Biologi-
cal Studies, San Diego, CA) and were used to generate sin-
gle-cycle luciferase reporter viruses. The other molecular
constructs and HIV-1 strains were obtained through the
AIDS Repository Reagent Program. The pHCMV-G plas-
mid codes for the broad host-range vesicular stomatitis
virus envelope glycoprotein G (VSV-G) and is placed
under the control of the human cytomegalovirus pro-
moter. HIV-1-based reporter viruses pseudotyped with
VSV-G were produced upon cotransfection of 293T cells
with pNL4-3Luc+E-R+ and pHCMV-G. Progeny viruses
were also produced upon acute infection of PBMCs and
purified CD4+ T cells for 7 days with two laboratory strains
of HIV-1 (i.e. JR-CSF and NL4-3Balenv) and the X4-tropic
clinical isolate 92HT599. The virus-containing superna-
tants were filtered through a 0.22 μm cellulose acetate
syringe filter and normalized for virion content using an
in-house sensitive double-antibody sandwich enzyme-
linked immunosorbent assay (ELISA) specific for the viral
p24 protein [54].
Virus transfer studies
DCs (3.3 × 104 cells in 100 μl) were pulsed with the stud-
ied virus preparations (10 ng of p24gag/105 cells) for 60
min at 37°C in absence or presence of various concentra-
tions of ATP. Next, the virus-cell mixture was washed three
times with phosphate-buffered saline (PBS) to remove
input virus. iDCs and mDCs were co-cultured with autol-
ogous activated CD4+ T lymphocytes (ratio 1:3) in com-
plete RPMI medium supplemented with IL-2 (30 U/ml) in
96-well plates in a final volume of 200 μl. Every two days,
half of the medium was removed and kept frozen at -20°C
and fresh medium was added to the culture. Virus produc-
tion was estimated by measuring the p24 levels in cell-free
culture supernatants. Infection with luciferase-encoding
viruses was assessed 3 days following initiation of the co-Page 12 of 15
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with NLHSA-IRES viruses were performed the same way
but using 3 × 105 iDC and 106 CD4+ T cells per sample.
Mock-infected cells were used as controls. Three days after
initiation of the co-culture, cells were stained either with
an isotype-matched irrelevant control antibody (i.e. IgG1)
or anti-CD3 followed by an FITC-conjugated goat anti-
mouse IgG and a biotin-conjugated anti-HSA followed by
R-PE-labeled streptavidin. Stained cells were fixed with
2% paraformaldehyde for 30 min at 4°C and then ana-
lyzed by flow cytometry (Epics ELITE ESP; Coulter Elec-
tronics, Burlington, ON). Single stained cells were also
used as controls for compensation adjustments.
Virus infection of iDCs and CD4+ T cells
De novo virus production in iDCs was monitored by incu-
bating such cells (5 × 105) with HIV-1 (50 ng of p24gag) for
60 min at 37°C in absence or presence of ATP. After three
washes with PBS, the cells were maintained in complete
culture medium supplemented with GM-CSF (1000 U/
ml) and IL-4 (200 U/ml). Purified CD4+ T cells were incu-
bated for 2 h with NL4-3Balenv (10 ng p24gag/105 cells) in
absence or presence of ATP. After three washes with PBS,
the cells were cultured in complete culture medium sup-
plemented with IL-2 (30 U/ml). Virus production was
estimated by assessing the p24 levels in cell-free culture
supernatants.
Virus entry and degradation assays
iDCs (105 cells) were incubated with NL4-3Balenv (10 ng
p24gag) in absence or presence of ATP for 60 min at 37°C.
Cells were then washed once with PBS, treated with
trypsin for 5 min at 37°C to remove all uninternalized vir-
ions, washed three times and then either immediately
lysed or incubated in 100 μl complete RPMI for 0, 1, 3, or
18 h. Cells were then separated from medium and the p24
contents were evaluated in both cells and cell-free culture
supernatants.
Statistical analysis
Statistical analyses were performed according to methods
outlined in Zar [55]. Means were compared using either
the Student's test or single factor ANOVA followed by
Dunnett's multiple comparison when more than two
means were considered. Results of three or four experi-
ments were always used for these analyses even when
results of one representative experiment were presented in
a Figure. Because infection levels vary largely among vari-
ous DC preparations, a repeated measures ANOVA test
had to be used. P-values of less than 0.05 were considered
statistically significant. The GraphPad InStat version 3.05
software (GraphPad Software, Inc) was used for all analy-
ses.
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